title: Calprotectin and spondyloarthritis.
authors.affiliation: a Department of Rheumatology , CHRU (University Teaching Hospital), Boulevard Fleming , Besançon , France.|b EA 4266, Université de Bourgogne Franche-Comté, Rue Goudimel , Besançon , France.
authors.forename: Daniel
authors.initials: D
authors.lastname: Wendling
authors.affiliation: a Department of Rheumatology , CHRU (University Teaching Hospital), Boulevard Fleming , Besançon , France.|c EA 4267, Université de Bourgogne Franche-Comté, Rue Goudimel , Besançon , France.
authors.forename: Frank
authors.initials: F
authors.lastname: Verhoeven
authors.affiliation: a Department of Rheumatology , CHRU (University Teaching Hospital), Boulevard Fleming , Besançon , France.|c EA 4267, Université de Bourgogne Franche-Comté, Rue Goudimel , Besançon , France.|d FHU INCREASE, CHRU , Besançon , France.
authors.forename: Clément
authors.initials: C
authors.lastname: Prati
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000378:metabolism*; D018450:Disease Progression; D005786:Gene Expression Regulation; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007249:Inflammation; D000069285:Infliximab / Q000627:therapeutic use; D039841:Leukocyte L1 Antigen Complex / Q000235:genetics / Q000378:metabolism*; D011379:Prognosis; D013167:Spondylitis, Ankylosing / Q000175:diagnosis* / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
chemical_list: D015415:Biomarkers; D039841:Leukocyte L1 Antigen Complex; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab
keywords: Spondyloarthritis; calprotectin; disease activity; gut; prognosis